Brief: India's Dr. Lal Pathlabs Sept-Quarter Consol Net Profit Rises
Nov 6 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS :
* INDIA'S DR. LAL PATHLABS SEPT-QUARTER CONSOL NET PROFIT 853 MILLION RUPEES
VERSUS 805 MILLION RUPEES YEAR AGO
* DR. LAL PATHLABS SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 4.32 BILLION
RUPEES
VERSUS 3.66 BILLION RUPEES YEAR AGO
* DR. LAL PATHLABS - BOARD DECLARED INTERIM DIVIDEND OF 6 RUPEES PER SHARE
Source text for Eikon: ID:nBSE7MDknj
Further company coverage: DLPA.NS
(((Reuters.Briefs@thomsonreuters.com);;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise